Episode 8. Management of Newly Diagnosed CLL
Blood Cancer Talks
00:00
Venerable Clacks and MRD Negative Permission
For example, venetoclax, or venetismab is supposed to begin for one year. Many times I check it at six months when they're in the middle of the treatment just to see where they are. Now, if they're MRD negative at that time, then obviously, it's very reassuring to the patient that they're MRd negative. We know that their progression fee survival is going to be better than if they were MRD positive. But we don't know too the right statement what to do if someone is still positive MRD at that time. So, that's something which is not yet clear.
Transcript
Play full episode
